Showing results (1411-1420 of 2,286) with videos related to
Sort By:
Pageof 229
HIV Medicine|December 10, 2013
Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapyG Sampériz, D Guerrero, M López, et al.HIV Medicine|December 10, 2013
A meta-analysis of the efficacy and safety of unboosted atazanavir compared with ritonavir-boosted protease inhibitor maintenance therapy in HIV-infected adults with established virological suppression after inductionJ Baril, B Conway, P Giguère, et al.HIV Medicine|October 15, 2013
Occult hepatitis B virus coinfection in HIV-positive African migrants to the UK: a point prevalence studyD Chadwick, T Doyle, S Ellis, et al.HIV Medicine|August 25, 2016
Euroguidelines in Central and Eastern Europe (ECEE) conference and the Warsaw Declaration - a comprehensive meeting reportJ D Kowalska, C Oprea, S de Witt, et al.HIV Medicine|February 26, 2010
Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical practiceJ Macías, J González, E Ortega, et al.HIV Medicine|January 12, 2010
Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe, K Boer, K England, et al.HIV Medicine|April 10, 2019
Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South AfricaP Bock, K Nel, G Fatti, et al.HIV Medicine|July 5, 2017
Epidemiology of tuberculosis and HIV coinfections in Singapore, 2000-2014K Nandar, L W Ang, J Tey, et al.HIV Medicine|May 11, 2018
Subclinical cardiovascular disease in patients starting contemporary protease inhibitorsA González-Cordón, M Doménech, M Camafort, et al.HIV Medicine|May 30, 2019
Summary of German-Austrian HIV PrEP guidelineC D Spinner, G F Lang, C Boesecke, et al.Pageof 229